Kiniksa Pharmaceuticals International, plc KNSA Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's change in AP?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported change in AP of $22.27M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's change in AP changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's change in AP increased by 35812.9% year-over-year, from $62K to $22.27M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.